Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation on unaudited financial results for the 31st december 201930-01-2020
30-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Unaudited Financial Results For The Quarter And 9 Months Ended 31St December 2019
Outcome of Board Meeting30-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call will hold on Friday 31st January 2020 at 02.00 PM28-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 25, 2020 for Akash Farms LLP25-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended December 31, 2019
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here20-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI DP Regulations, 2018.15-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI DP Regulations, 2018.15-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- DHIRAJ RATHIDesignation :- Company Secretary and Compliance Officer14-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Month Period Ended 31St December 2019.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2020 ,inter alia, to consider and approve unaudited financial results for the quarter and nine month period ended 31st December 2019.11-01-2020
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Authum Investment and Infrastructure Ltd08-01-2020